tiprankstipranks
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Holding AU:SNT?
Track your performance easily

Pharmaxis Ltd (SNT) Income Statement

3 Followers

Pharmaxis Ltd Income Statement

Last quarter (Q4 2022), Pharmaxis Ltd's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Pharmaxis Ltd's net income was AU$―. See Pharmaxis Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-AU$ 7.43MAU$ 6.68MAU$ 7.03MAU$ 5.68MAU$ 7.28M
Cost of Revenue
------
Gross Profit
-AU$ 7.43MAU$ 6.68MAU$ 7.03MAU$ 5.68MAU$ 7.28M
Operating Expense
-AU$ 30.19MAU$ 27.32MAU$ 28.49MAU$ 31.56MAU$ 33.63M
Operating Income
-AU$ -22.77MAU$ -20.64MAU$ -21.47MAU$ -25.88MAU$ -26.35M
Net Non Operating Interest Income Expense
-AU$ 13.61MAU$ -319.00KAU$ 2.52MAU$ 671.00KAU$ 35.00K
Other Income Expense
-AU$ 7.22MAU$ 17.99MAU$ 5.00MAU$ 5.16MAU$ 32.57M
Pretax Income
-AU$ -1.94MAU$ -2.97MAU$ -13.94MAU$ -20.06MAU$ 6.42M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ -8.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -1.94MAU$ -2.97MAU$ -13.94MAU$ -20.06MAU$ 6.43M
Basic EPS
-AU$ >-0.01AU$ >-0.01AU$ -0.04AU$ -0.05-
Diluted EPS
-AU$ >-0.01AU$ >-0.01AU$ -0.04AU$ -0.05-
Basic Average Shares
-AU$ 562.90MAU$ 407.28MAU$ 394.74MAU$ 381.39M-
Diluted Average Shares
-AU$ 562.90MAU$ 407.28MAU$ 394.74MAU$ 381.39M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -1.94MAU$ -2.97MAU$ -13.94MAU$ -20.06MAU$ 6.43M
Normalized Income
-AU$ -1.94MAU$ -2.97MAU$ -13.94MAU$ -20.06MAU$ 6.43M
Interest Expense
-AU$ -13.46MAU$ 369.00K-AU$ 238.00KAU$ 563.00K
EBIT
-AU$ -15.39MAU$ -2.60MAU$ -21.47MAU$ -19.82MAU$ 6.98M
EBITDA
-AU$ -12.15MAU$ 551.00KAU$ -18.23MAU$ -17.20MAU$ 10.33M
Currency in AUD

Pharmaxis Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis